Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Other Accumulated Expenses (2021 - 2025)

Updated

Celularity's Other Accumulated Expenses was $300,000 in Q4 2025.

Analysis

Celularity (CELU) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

  • The Q4 2025 figure marks the highest quarterly Other Accumulated Expenses since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Celularity 46.69 Mn 39.16 Mn 2.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 300,000.00
Sep 30, 2021 3.05 Mn
API Access

Celularity Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEY